Endothelial cell-expressed Tim-3 facilitates metastasis of melanoma cells by activating the NF-κB pathway

Oncology Reports

Volumn 24, Issue 3, 2010, Pages 693-699

  Wu, Feng Hua ^a   Yuan, Ye ^a   Li, Dong ^a   Lei, Zhang ^a   Song, Chuan Wang ^a   Liu, Yan Yan ^a   Li, Bo ^a   Huang, Bo ^a   Feng, Zuo Hua ^a   Zhang, Gui Mei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Endothelial cells; NF B pathway; Tim 3; Tumor metastasis

Indexed keywords

ECALECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN 3; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL PROLIFERATION; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; ENDOTHELIAL CELLS; HMGB1 PROTEIN; LIGANDS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NF-KAPPA B; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, VIRUS; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 77956304083     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000909     Document Type: Article

References (28)

1. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18, 2002.
2. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
3. Pober JS and Sessa WC: Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7: 803-815, 2007.
4. Van Beijnum JR, Buurman WA and Griffioen AW: Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11: 91-99, 2008.
5. Chen LC, Gordon RE, Laskin JD and Laskin DL: Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia. Exp Mol Pathol 83: 311-326, 2007.
6. Fitzner N, Clauberg S, Essmann F, Liebmann J and Kolb-Bachofen V: Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands. Clin Vaccine Immunol 15: 138-146, 2008. (Pubitemid 351966534)
7. Meroni PL, Raschi E, Testoni C, Parisio A and Borghi MO: Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun Rev 3: 510-515, 2004.
8. Kuchroo VK, Meyers JH, Umetsu DT and DeKruyff RH: TIM family of genes in immunity and tolerance. Adv Immunol 91: 227-249, 2006.
9. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB and Kuchroo VK: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6: 1245-1252, 2005.
10. Van de Weyer PS, Muehlfeit M, Klose C, Bonventre JV, Walz G and Kuehn KW: A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem Biophys Res Commun 351: 571-576, 2006. (Pubitemid 44666725)
11. Wiener Z, Kohalmi B, Pocza P, Jeager J, Tolgyesi G, Toth S, Gorbe E, Papp Z and Falus A: TIM-3 is expressed in melanoma cells and is up-regulated in TGF-beta stimulated mast cells. J Invest Dermatol 127: 906-914, 2007.
12. + T cells in murine acute graft-versus-host disease. J Immunol 177: 4281-4287, 2006.
13. Renesto PG, Ponciano VC, Cenedeze MA, Saraiva Câmara NO and Pacheco-Silva A: High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant 7: 1661-1665, 2007.
14. Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Barrett MA, Rose NR and Fairweather D: Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 178: 6710-6714, 2007. (Pubitemid 46847392)
15. Kearley J, McMillan SJ and Lloyd CM: Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med 204: 1289-1294, 2007.
16. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 66: 1123-1131, 2006.
17. Gong W, Liu Y, Huang B, Lei Z, Wu FH, Li D, Feng ZH and Zhang GM: Recombinant CBD-HepII polypeptide of fibronectin inhibits alphavbeta3 signaling and hematogenous metastasis of tumor. Biochem Biophys Res Commun 367: 144-149, 2008.
18. Geng H, Zhang GM, Li D, Zhang H, Yuan Y, Zhu HG, Xiao H, Han LF and Feng ZH: Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J Immunol 176: 1411-1420, 2006. (Pubitemid 43134283)
19. Wada J, Ota K, Kumar A, Wallner EI and Kanwar YS: Developmental regulation, expression and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 99: 2452-2461, 1997. (Pubitemid 27227724)
20. Huang B, Zhao J, Unkeless JC, Feng ZH and Xiong H: TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27: 218-224, 2008.
21. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK and Hafler DA: Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318: 1141-1143, 2007. (Pubitemid 350134897)
22. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH and Suffredini AF: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101: 2652-2660, 2003.
23. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tör M and Billiar T: The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 220: 60-81, 2007. (Pubitemid 350045579)
24. Raucci A, Palumbo R and Bianchi ME: HMGB1: a signal of necrosis. Autoimmunity 40: 285-289, 2007.
25. Aychek T, Miller K, Sagi-Assif O, Levy-Nissenbaum O, Israeli-Amit M, Pasmanik-Chor M, Jacob-Hirsch J, Amariglio N, Rechavi G and Witz IP: E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release. Int J Cancer 123: 1741-1750, 2008.
26. Laferriere J, Houle F, Taher MM, Valerie K and Huot J: Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem 275: 33762-33772, 2001.
27. Laferriere J, Houle F and Huot J: Adhesion of HT-29 colon carcinoma cells to endothelial cells requires sequential events involving E-selectin and integrin beta4. Clin Exp Metastasis 21: 257-264, 2004. (Pubitemid 39158503)
28. Tremblay PL, Auger FA and Huot J: Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 25: 6563-6573, 2006.